Virus-induced interference as a means for accelerating fitness-based selection of cyprinid herpesvirus 3 single-nucleotide variants <i>in vitro</i> and <i>in vivo</i>.
Journal Information
Full Title: Virus Evol
Abbreviation: Virus Evol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Conflict of interest: Alain Vanderplasschen is the author of patents related to the development of Cyprinid herpesvirus 3 attenuated vaccines."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by the University of Liège (ARC15/19-12), the Fonds National Belge de la Recherche Scientifique (FNRS) (CDR J.0094.15 and PDR T.0241.19), the Welbio (WELBIO-CR-2022 A-14 12), the European Maritime and Fisheries Fund (Eel4ever project), the international coordination of research on animal diseases (ICRAD, NucNanoFish), and the Medical Research Council (MC_UU_12014/3)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025